Issue Code: CPT
2,262
531
322
2025--2026
8 activities
ACG ADVOCACY
111 activities
MARLA GROSSMAN LLC
83 activities
RADIUS ADVOCACY, LLC
53 activities
TWINLOGIC STRATEGIES, LLP
44 activities
ALIGNMENT GOVERNMENT STRATEGIES
44 activities
NVG, LLC
40 activities
FRANKLIN SQUARE GROUP, LLC
40 activities
MILLER STRATEGIES, LLC
34 activities
AKIN GUMP STRAUSS HAUER & FELD
32 activities
CROSSROADS STRATEGIES, LLC
28 activities
HOUSE OF REPRESENTATIVES
1,983 mentionsSENATE
1,965 mentionsPatent & Trademark Office (PTO)
279 mentionsCommerce, Dept of (DOC)
222 mentionsU.S. Copyright Office
161 mentionsWhite House Office
118 mentionsU.S. Trade Representative (USTR)
110 mentionsOffice of Science & Technology Policy (OSTP)
63 mentionsJustice, Dept of (DOJ)
56 mentionsState, Dept of (DOS)
50 mentionsSTM
via WEINREICH STRATEGIC GROUP, INC.
Protection of copyright, rights of contract, licensing, and academic freedom
INTERNATIONAL ANTICOUNTERFEITING COALITION INC
via THE INTERNATIONAL ANTICOUNTERFEITING COALITION, INC.
Support for the enactment of provisions to clarify and expand the authority of CBP to share intelligence with private sector stakeholders to facilitate public-private partnership in the context of IP enforcement. H.R. 4930; S. 2677
COLOSSAL BIOSCIENCES INC.
via MILLER STRATEGIES, LLC
Issues related to the U.S. Patent Office, federal grants, de-extinction, and regulatory landscape of synthetic biology.
SPORTS & FITNESS INDUSTRY ASSOCIATION
via SPORTS & FITNESS INDUSTRY ASSOCIATION
Not active this past quarter
FRESENIUS KABI USA LLC
via FRESENIUS KABI USA LLC
PTAB Proposed Rule - Restrict Use of IPR Patent Legislation Ancillary Product Patent Reform Clinical Trials for Biosimilars; Interchangeability Biosimilar Market Entry through Regulatory Streamlining
TOUR TECH LLC
via KLEIN/JOHNSON GROUP
Performance licensing
FUEL ETHANOL DISRUPTIVE BIOTECHNOLOGY RESEARCH CENTER INCORPATED
via MR. AMIR GOULART SCHARIF
Engaged in research and development activities in The United States' energy independence strategy
FUEL ETHANOL DISRUPTIVE BIOTECHNOLOGY RESEARCH CENTER INCORPATED
via MR. AMIR GOULART SCHARIF
Engaged in research and development activities in The United States' energy independence strategy
DR. BROWNS COMPANY
via DB3, LLC (FKA THE DASCHLE GROUP)
Advocacy related to trade enforcement, consumer product safety, intellectual property protection, online marketplace practices, and regulatory policy affecting U.S. manufacturers of maternal and infant health products.
STM
via WEINREICH STRATEGIC GROUP, INC.
Protection of copyright, rights of contract, licensing, and academic freedom